Visioneering Technologies, Inc. (VTI.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.85 Million AUD | -8.27% |
| 2022 | -5.55 Million USD | -176.63% |
| 2021 | -2 Million AUD | 75.03% |
| 2020 | -8.03 Million AUD | 36.87% |
| 2019 | -12.73 Million AUD | 25.07% |
| 2018 | -16.99 Million AUD | -8.74% |
| 2017 | -15.62 Million AUD | -187.46% |
| 2016 | -5.43 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -1.44 Million USD | -0.37% |
| 2023 Q3 | -1.6 Million USD | -11.48% |
| 2023 FY | -6.01 Million AUD | -8.27% |
| 2023 Q4 | -1.51 Million USD | 5.68% |
| 2023 Q1 | -1.43 Million USD | 24.93% |
| 2022 Q3 | -2.03 Million USD | 11.78% |
| 2022 Q4 | -1.91 Million USD | 6.05% |
| 2022 FY | -5.55 Million USD | -176.63% |
| 2022 Q2 | -2.31 Million USD | 0.0% |
| 2021 FY | -2 Million AUD | 75.03% |
| 2020 FY | -8.03 Million AUD | 36.87% |
| 2019 Q2 | -4.51 Million AUD | 0.0% |
| 2019 Q1 | -4.51 Million AUD | 0.0% |
| 2019 FY | -12.73 Million AUD | 25.07% |
| 2018 Q1 | -5.99 Million AUD | 0.0% |
| 2018 FY | -16.99 Million AUD | -8.74% |
| 2018 Q4 | -4.51 Million AUD | 0.0% |
| 2018 Q2 | -5.99 Million AUD | 0.0% |
| 2017 Q1 | -4.08 Million AUD | 0.0% |
| 2017 Q2 | -4.08 Million AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | -15.62 Million AUD | -187.46% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q4 | -4.08 Million AUD | 0.0% |
| 2016 FY | -5.43 Million AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 79.067% |
| Adherium Limited | -11.98 Million AUD | 51.156% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 40.189% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -34.223% |
| Anteris Technologies Ltd | -66.63 Million AUD | 91.214% |
| Control Bionics Limited | -5.92 Million AUD | 1.267% |
| CardieX Limited | -4.63 Million AUD | -26.338% |
| Compumedics Limited | -269 Thousand AUD | -2076.256% |
| Cochlear Limited | 521.5 Million AUD | 101.123% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -21.607% |
| Cyclopharm Limited | -9.22 Million AUD | 36.538% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -262.617% |
| Nova Eye Medical Limited | -3.79 Million AUD | -54.178% |
| HeraMED Limited | -6.42 Million AUD | 8.928% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 66.691% |
| ImpediMed Limited | -19.03 Million AUD | 69.247% |
| InhaleRx Limited | -1.38 Million AUD | -322.227% |
| LBT Innovations Limited | -4.74 Million AUD | -23.505% |
| Micro-X Limited | -13.02 Million AUD | 55.062% |
| Neurotech International Limited | -5.58 Million AUD | -4.823% |
| OncoSil Medical Limited | -11.98 Million AUD | 51.151% |
| PolyNovo Limited | 1.16 Million AUD | 603.364% |
| Respiri Limited | -7 Million AUD | 16.372% |
| SomnoMed Limited | -3.84 Million AUD | -52.4% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 64.904% |
| Uscom Limited | -2.4 Million AUD | -143.481% |